Weak Base Permeability Characteristics Influence the Intracellular Sequestration Site in the Multidrug-resistant Human Leukemic Cell Line HL-60

Muralikrishna Duvvuri, Yuping Gong, Dev Chatterji, Jeffrey P. Krise

Journal of Biological Chemistry · 2004 · 101 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

A number of organelles contained within mammalian cells have been implicated in the selective sequestration of chemical entities including drug molecules. Specifically, weakly basic molecules have been shown to selectively associate with either the mitochondrial compartment or lysosomes; however, the structural basis for this differentiation has not been understood. To investigate this, we have identified a series of seven weakly basic compounds, all with pKa near neutrality, which have different sequestration sites within the multidrug-resistant HL-60 human leukemic cell line. Three of the compounds were selectively sequestered into the mitochondria of the cells, whereas the remainder were predominantly localized within lysosomes. Using specific chemical inhibitors to disrupt either mitochondrial or lysosomal accumulation capacity, we demonstrated that accumulation of these compounds into respective organelles are not competitive processes. Comparison of the permeability characteristics of these compounds as a function of pH revealed striking differences that correlate with the intracellular sequestration site. Only those compounds with significantly reduced permeability in the ionized state relative to the un-ionized state had the capacity to accumulate within lysosomes. Alternatively, those compounds with relatively pH-insensitive permeability selectively accumulated into mitochondria. Using novel quantitative assays for assaying drug accumulation into subcellular organelles, we demonstrated a correlation between these permeability characteristics and the lysosomal versus mitochondrial accumulation capacity of these compounds. Together, these results suggest that the selective accumulations of weakly basic compounds in either lysosomes and mitochondria occur via exclusive pathways governed by a unique permeability parameter. A number of organelles contained within mammalian cells have been implicated in the selective sequestration of chemical entities including drug molecules. Specifically, weakly basic molecules have been shown to selectively associate with either the mitochondrial compartment or lysosomes; however, the structural basis for this differentiation has not been understood. To investigate this, we have identified a series of seven weakly basic compounds, all with pKa near neutrality, which have different sequestration sites within the multidrug-resistant HL-60 human leukemic cell line. Three of the compounds were selectively sequestered into the mitochondria of the cells, whereas the remainder were predominantly localized within lysosomes. Using specific chemical inhibitors to disrupt either mitochondrial or lysosomal accumulation capacity, we demonstrated that accumulation of these compounds into respective organelles are not competitive processes. Comparison of the permeability characteristics of these compounds as a function of pH revealed striking differences that correlate with the intracellular sequestration site. Only those compounds with significantly reduced permeability in the ionized state relative to the un-ionized state had the capacity to accumulate within lysosomes. Alternatively, those compounds with relatively pH-insensitive permeability selectively accumulated into mitochondria. Using novel quantitative assays for assaying drug accumulation into subcellular organelles, we demonstrated a correlation between these permeability characteristics and the lysosomal versus mitochondrial accumulation capacity of these compounds. Together, these results suggest that the selective accumulations of weakly basic compounds in either lysosomes and mitochondria occur via exclusive pathways governed by a unique permeability parameter. The development of the multidrug-resistant (MDR) 1The abbreviations used are: MDR, multidrug-resistant; QNC, quinacrine; DNP, 2,4-dinitrophenol; HAR, harmine; PAP, papaverine; NF, New Fuchsin; LTR, Lysotracker Red DND-99; R123, rhodamine 123; R6G, rhodamine 6G; PBS, phosphate-buffered saline; FeDex, iron dextran; HPLC, high pressure liquid chromatography; TRITC, tetramethylrhodamine isothiocyanate. 1The abbreviations used are: MDR, multidrug-resistant; QNC, quinacrine; DNP, 2,4-dinitrophenol; HAR, harmine; PAP, papaverine; NF, New Fuchsin; LTR, Lysotracker Red DND-99; R123, rhodamine 123; R6G, rhodamine 6G; PBS, phosphate-buffered saline; FeDex, iron dextran; HPLC, high pressure liquid chromatography; TRITC, tetramethylrhodamine isothiocyanate. phenotype in cancer cells is associated with a variety of physiological and biochemical changes (1Gottesman M.M. Pastan I. Annu. Rev. Biochem. 1993; 62: 385-427Google Scholar, 2Simon S. Roy D. Schindler M. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 1128-1132Google Scholar). Our laboratory investigated the intracellular drug sequestration pathways associated with the emergence of this drug-resistant phenotype. We have recently shown that selective accumulation of anticancer drugs in cellular organelles of the MDR human leukemic cell line HL-60 can be associated with decreased drug effectiveness (3Gong Y. Duvvuri M. Krise J.P. J. Biol. Chem. 2003; 278: 50234-50239Google Scholar). Moreover, we also have shown that different organelles are able to sequester drugs with different structural attributes according to independent mechanisms. A remaining paradox in this field of research has to do with the intracellular sequestration site of weakly basic compounds. We along with others have shown that certain weakly basic compounds (i.e. daunorubicin, doxorubicin) with pKa values near neutrality are selectively sequestered into lysosomes of MDR cell lines (3Gong Y. Duvvuri M. Krise J.P. J. Biol. Chem. 2003; 278: 50234-50239Google Scholar, 4Hurwitz S.J. Terashima M. Mizunuma N. Slapak C.A. Blood. 1997; 89: 3745-3754Google Scholar). Alternatively, other weakly basic compounds, also with pKa near neutrality, specifically accumulate within the mitochondria of cells (i.e. rhodamine 123) (5Haugland R.P. Gregory J. Handbook of Fluorescent Probes and Research Products. 9th Ed. Moleuclar Probes, Inc., Eugene, OR2002: 483Google Scholar). Independent theories have been put forth to describe weak base sequestration into each of these compartments; however, a physicochemical parameter that can be used to predict the intracellular sequestration site has not been elucidated. Selective accumulation of weakly basic drugs into the lysosomal compartment of MDR cells is thought to occur according to a pH partitioning type of mechanism that relies on the low pH of lysosomes relative to the cell cytosol (6Skovsgaard T. Mihich E. Transport and Multidrug Resistance. John Libbey and Co., New York1990: 209Google Scholar, 7Moriyama Y. J. Exp. Biol. 1996; 199: 1447-1454Google Scholar, 8Altan N. Chen Y. Schindler M. Simon S.M. J. Exp. Med. 1998; 187: 1583-1598Google Scholar). In the MDR HL-60 cell line, we have previously determined that the pH values associated with the lysosomal lumen and cell cytosol are 5.2 and 7.1, respectively (3Gong Y. Duvvuri M. Krise J.P. J. Biol. Chem. 2003; 278: 50234-50239Google Scholar). Following permeation through the cell membrane, weakly basic drugs with pKa near neutrality would exist to a significant degree in their un-ionized membrane-permeable form in the cytosol. In this form, they are able to diffuse through the lysosomal lipid bilayer and enter the lumen. Here in the acidic environment, the base would exist predominantly in the ionized form. Because ionized forms of drugs are traditionally thought to be membrane impermeable, the weak base becomes trapped within the lysosome, which can lead to significant accumulation as long as the pH gradient is maintained. The accumulation mechanism for weak bases into the mitochondrial compartment is driven by the negative membrane potential associated with this organelle. The mitochondrial transmembrane proton motive force, which is generated by oxidative phosphorylation, results in both a pH differential (more alkaline inside) and an electrical potential (more negative inside) (9Rottenberg H. Methods Enzymol. 1979; 55: 547-569Google Scholar). This membrane potential difference has been estimated to be –150 to –170 mV and can result in the accumulation of cationic molecules several hundred-fold over cytoplasmic concentrations (10Smith R.A.J. Porteous C.M. Gane A.M. Murphy M.P. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 5407-5412Google Scholar). The site of intracellular sequestration of weakly basic compounds is an important consideration for effective drug targeting. Drug targets are typically housed within specific cellular compartments, and the ability of a drug to accumulate therein has a bearing on drug activity and specificity. The quest to specifically target novel anticancer agents to the mitochondrial compartment has received much recent interest and many lipophilic cationic molecules have been evaluated as anticancer agents (11Modica-Napolitano J.S. Aprille J.R. Adv. Drug Delivery Rev. 2001; 49: 63-70Google Scholar). Significant accumulation of such compounds into the mitochondria has varied effects; nevertheless, the end result is often diminished cellular ATP production, which in turn triggers cell death (11Modica-Napolitano J.S. Aprille J.R. Adv. Drug Delivery Rev. 2001; 49: 63-70Google Scholar). From a drug delivery point of view, the attractiveness of this therapeutic approach is centered on the finding that cancer cells have increased negative membrane potential relative to nontransformed cells (11Modica-Napolitano J.S. Aprille J.R. Adv. Drug Delivery Rev. 2001; 49: 63-70Google Scholar). This difference is expected to result in a 10-fold higher concentration in the mitochondria of cancer cells than those of nontransformed cells. Unfortunately, the design of mitochondrially targeted, weakly basic anticancer drugs has been complicated by the fact that many of these agents are sequestered by lysosomes, which diminishes the aforementioned specificity. Furthermore, the effectiveness of many traditional weakly basic anticancer agents is also lessened as a result of lysosomal sequestration in MDR cancer cells. Many of these agents (i.e. daunorubicin, doxorubicin) have nuclear targets including DNA and topoisomerase (12Binaschi M. Bigioni M. Cipollone A. Rossi C. Goso C. Maggi C.A. Capranico G. Animati F. Curr. Med. Chem. Anti-Canc. Agents. 2001; 1: 113-130Google Scholar). Consequently, lysosomal sequestration results in reduced interactions with targets and decreased effectiveness. Taken together, drug design efforts would greatly benefit from an understanding of physicochemical parameters that predictably influence intracellular localization. To address this paradox we have evaluated the physicochemical properties of a series of weakly basic compounds that are preferentially sequestered into lysosomes or mitochondria. We report here that the permeability of the ionized species relative to un-ionized species is a principal determinant of subcellular distribution. The doxorubicin-selected resistant human acute promyeloid leukemia cell line MDR HL-60 was kindly provided by Dr. Yueshang Zhang (Arizona Cancer Center, University of Arizona). MDR HL-60 cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum, 10 mm Hepes, 1 mm sodium pyruvate, 0.1% penicillin, and 0.1% streptomycin. The cells were maintained at a density of 1 × 105 to 1 × 106 cells/ml at 37 °C in a humidified 5% CO2 atmosphere. Quinacrine (QNC) and 2,4-dinitrophenol (DNP) were kindly provided by Dr. Moo Cho (School of Pharmacy, University of North Carolina-Chapel Hill). Harmine (HAR), papaverine (PAP), New Fuchsin (NF), 1-octanol and concanamycin A (Con A) were purchased from Sigma. Lysotracker Red DND-99 (LTR), rhodamine 123 (R123), and rhodamine 6G (R6G) were obtained from Molecular Probes (Eugene, OR). Fluorescence Microscopy—Cells were grown to a density of 1 × 106 cells/ml prior to experimentation. The cells were incubated with the indicated compound (1 μm) for 2 h under normal growth conditions. Following incubation, the cells were pelleted (1000 rpm, 5 min) and washed twice with ice-cold PBS to remove any unincorporated compound. Disruption of lysosome-to-cytosol pH gradient was achieved with a 24-h pre-incubation with 20 nm Con A. Disruption of mitochondrial membrane potential was achieved with a 30-min pre-incubation of cells with 100 μm DNP. The cells were viewed with a microscope (Leica Diaplan, Leitz Weltzar, Germany) equipped for epifluorescence with a 100× objective, and images were captured using an Orca ER camera (Hamamatsu Corp.) controlled by SimplePCI imaging software (Compix Inc.). R6G and LTR utilized a Texas Red filter set, whereas a fluorescein filter set was employed for QNC and R123. pH Partition Experiments—The pH partition behavior of each test compound was evaluated in n-octanol/buffer systems using the shake-flask method (13Rivory L.P. Avent K.M. Pond S.M. Cancer Chemother. Pharmacol. 1996; 38: 439-445Google Scholar). Briefly, the test compounds were dissolved to a final concentration of 1 μm in 10 of an 5 mm Hepes, 5 mm 5 mm and mm pH with or 1-octanol was and the was for at The were by at for 10 of each were and for compound using a partition of ionized and un-ionized base were obtained by the pH partition for QNC, LTR, HAR, and using Inc., using the NF, R123, and R6G, and were estimated as partition at pH values and the The of to was as the values for test compounds were obtained by the of the pKa pKa values for QNC, LTR, HAR, and were obtained by the respective pH partition as under Partition The pKa values for the rhodamine were obtained by the in as a function of was to that used for pH partition Fluorescence were using a The and used for were and nm and for R6G, and The pH versus were using with the and the pKa was The pKa for was obtained by the in at nm as a function of was to that used for pH partition were using a The pH versus was using with the and the pKa was of from MDR HL-60 were using a approach by 1998; with iron were as MDR HL-60 cells × 106 were incubated with for 1 h at 37 °C in PBS, pH to for Following the incubation, the cells were washed with PBS and incubated in medium at 37 °C for h to for the specific lysosomal of the end of the the cells were washed twice with ice-cold PBS and in 2 of mm mm 1 mm and 10 mm supplemented with mm and 1 each and The cells were in a using the To the was of mm mm 1 mm and mm at pH and at for 10 to the and cells. The was through a contained in a The had been previously with of in the of PBS were to through the and to in the for 10 The was washed with of ice-cold The were with PBS that was to for 10 prior to of the from the The was in lysosomes from other cellular of the cellular lysosomes were in this of as evaluated using assays by M. J. D. Biochem. 1994; Scholar). of from MDR HL-60 was according to a previously by laboratory M. A. Krise J.P. Scholar). of cytosol in the was on this of from MDR HL-60 differential method was to an of mitochondria with lysosomal Briefly, 2 of was generated from × 106 MDR HL-60 cells as under of from MDR HL-60 The was on of a 1 and at for The was in mitochondria significant from other This contained of cellular mitochondria as evaluated using assays of of in and and lysosomes were from MDR HL-60 cells incubated previously with compound for of these cellular was for with of and at for 5 The was to and the was dissolved in 100 and The of compound from each cellular was of each compound from and mitochondrial were determined and in This is to for the of compound from each cellular the and were determined by of each test compound different and low into cellular and the in the were with for all the test compounds from to To lysosomal accumulation between compounds, the of each compound in lysosomes was by that in cytosol. This was as the of lysosomal This was to for the permeability differences between compounds. the of mitochondrial accumulation for each compound was obtained by the of compound in mitochondria to that in cytosol. To versus mitochondrial accumulation of compounds, the of lysosomal accumulation was by the of mitochondrial In all the quantitative and were and the A was The contained in 10 mm The of in the for each compound was as for HAR, for PAP, for QNC and R123, for LTR and NF, and for In the for R6G of A was used to R123, R6G, HAR, LTR, and The and for the compounds were as QNC LTR and R6G and were using a at nm and of physicochemical parameters that influence lysosomal versus mitochondrial accumulation was achieved by a series of seven weakly basic compounds. The of these compounds are shown in and R6G are that have been shown to specifically associate with the mitochondrial of these cells. QNC and LTR are compounds that have been shown to specifically accumulate within the lysosomes of cells. To the of we weakly basic compounds for this which had pKa values that are near This is an important the pKa of the weak base would be expected to predictably influence both lysosomal and mitochondrial accumulation The determined pKa values for each of these compounds are shown in I. In to the compounds, we the weak bases HAR, PAP, and NF, all of which had pKa values near however, their intracellular were properties of test determined determined are of determined are of determined are of in a of and fact that QNC, LTR, R123, and R6G are to their intracellular using MDR HL-60 cells incubated with these compounds intracellular accumulation the for sequestration Using either fluorescein or we have that LTR and QNC with lysosomes; and R6G were shown to with mitochondrial Red or are shown in of We have shown previously that of MDR HL-60 cells with Con a specific pH to from 5.2 to which results in a in the lysosome-to-cytosol pH Con cells are incubated with LTR and QNC, the lysosomal accumulation is significantly with the mechanism for lysosomal accumulation of these compounds The mitochondrial accumulation of and R6G are not by Con A is an that has been shown to specifically disrupt the mitochondrial membrane potential 1998; Scholar). with had a significantly reduced capacity to sequester and R6G into the mitochondrial whereas this not significantly influence the lysosomal sequestration of LTR and is important to that in Con cells, LTR and QNC are localized within the cell and are by into the mitochondrial and R6G not accumulate into lysosomes the mitochondrial membrane potential was with DNP. Con A and and mitochondria of the lysosomal membrane that cells with pH had lysosomal to cells pH of the mitochondrial membrane that of mitochondrial membrane potential with not the of mitochondria of Furthermore, we have that Con A not result in of into lysosomes. QNC not into mitochondria of these the of membrane potential in the mitochondrial sequestration of and R6G as as the lysosome-to-cytosol pH differential in the lysosomal sequestration of LTR and these suggest that the sequestration are independent of and are not competitive in the of The of basic compounds can exist in the un-ionized or ionized form on the pH of their and the pKa of the basic is thought that ionized compounds have reduced permeability lipid relative to un-ionized compounds. The fact that mitochondrial compounds to be sequestered into lysosomes in the of to the that these compounds had permeability To this we determined the partition as a function of pH for the compounds shown in compounds with the for lysosomal accumulation and a for a weak A from this of compounds is shown in QNC these the ionized base pH has a significantly reduced partition relative to the un-ionized base pH In striking those compounds with the to accumulate into mitochondria and had partitioning behavior for a Using these we a parameter that was used to describe this permeability The of the of the ionized form relative to the un-ionized form was from these and was The values for agents were whereas the values for mitochondrial compounds were near this we on a quantitative correlation between and lysosomal is a approach for differences in cellular of compounds, is not to be we a novel approach to the of drug contained within the lysosomes. This a of cells with Following the the was specifically accumulated within the lysosomes of cells. The cells were incubated with and through a that lysosomes and Drug contained within the lysosomes was and by the of compound accumulated in lysosomes was to that in cytosol to for the permeability differences between the compounds. of cell cytosol from MDR HL-60 cells was by a previously by laboratory M. A. Krise J.P. Scholar). The lysosome-to-cytosol accumulation for each of the compounds, previously evaluated was their respective shown in this lysosomal accumulation with determined values in an Furthermore, and R6G to significant lysosomal accumulation results from not The fact that the high compounds and R6G preferentially accumulated in the mitochondria to investigate the of a weak base be used to predict lysosomal versus mitochondrial accumulation Our was that compounds with low values accumulate predominantly in the lysosomes. those compounds high in values accumulate predominantly in the mitochondria. To test this we a method to mitochondrial accumulation of the compounds in MDR HL-60 cells. of an mitochondrial was using a differential Using we demonstrated that mitochondrial of the lysosomal was and of Drug contained within the mitochondrial was and using The of the of each compound in the lysosomes to that in the mitochondria was the values of the compounds. A of values for compounds evaluated in this are shown in I. results in 5 demonstrated a correlation between and lysosomal versus mitochondrial with low values (i.e. had a higher to accumulate within lysosomes those compounds with high values (i.e. were shown to significantly accumulate within the mitochondrial compartment of the cell Furthermore, the weak bases PAP, HAR, and NF, with previously intracellular a with We demonstrated here a between a physicochemical parameter of weakly basic compounds and their intracellular site. with the of lysosomes, had a the basis for lysosomal accumulation of weak bases C. T. A. F. Biochem. Pharmacol. Scholar). In that the weak bases with pKa near neutrality are the for lysosomal on a pH partitioning on pH in the MDR HL-60 cell line, all of the compounds shown in 1 are expected to significant lysosomal lipophilic cationic compounds, such as and R6G, pKa near neutrality do not to significantly accumulate within the lysosomes of the Alternatively, these compounds preferentially accumulate in the mitochondrial The for mitochondrial accumulation of these high compounds is thought to be the negative membrane potential associated with this relative to the potential in the cytosol of the The selective accumulation of and R6G into the mitochondrial compartment with significant lysosomal sequestration can be in at accumulation in both with a mitochondrial Alternatively, compounds physicochemical attributes that for lysosomal Our results the In 2 we that and R6G to accumulate into lysosomes in the of DNP, a mitochondrial membrane This result is also through quantitative of the lysosomal accumulation for and R6G with and these was significant in the of lysosomal accumulation not a we that has influence on the lysosomal accumulation of LTR and Our which identified and R6G as compounds that to accumulate into lysosomes the fact that they were both weakly basic and had pKa neutrality, were to the basis for the of lysosomal sequestration of and R6G, several important were we that and R6G be able to partition into the lumen of the This was the permeability values of the un-ionized forms of these compounds were and with the compounds In fact R6G had a higher than We also the determined pKa values and lysosomal that these molecules be ionized contained within the lumen of lysosomes. From these we that the difference be that and R6G can diffuse of the in their ionized whereas QNC and LTR This difference is in the of partition as a function of pH shown in and R6G have in which the partition not significantly of the To this we values from the in The a novel physicochemical parameter that has received in the We here for the the of this parameter in the properties of weakly basic compounds. F. Chem. J. have previously on the influence of on the partition of weakly basic compounds. have demonstrated using that results in reduced capacity in This in turn the of from an to a environment, which is by increased partition for ionized This is in with the results in can be from the of compounds in and R6G have a degree of and membrane permeability they exist predominantly in the ionized form. Alternatively, the ionized forms of QNC and LTR have localized which their permeability through lysosomal lipid In quantitative we an correlation between and the of lysosomal accumulation In of lysosomal versus mitochondrial accumulation that an in not the of lysosomal accumulation also results in an in mitochondrial is to that a set of weakly basic compounds HAR, and with pKa near neutrality and previously intracellular a with results suggest that the can be used to predict the lysosomal versus mitochondrial accumulation To this the that a quantitative approach was used to correlate the physicochemical properties of a compound with intracellular site. The in this suggest that relatively physicochemical can a to a the for lysosomal versus mitochondrial accumulation of weakly basic compounds incubated with cells. be for compounds obtained from a of drug this can be in the design of drugs with subcellular sites and and with

References

11